CD33 and acute myeloid leukemia: When examining the false-positive inv(16)/t(16;16) AML cases, the NAPS diagram (Figures 7A–C) allowed for the identification of AML cases lacking the expression of CD13 or CD33 expression (Figure 7A, C); however, this difference in expression was not associated with any specific mutation patterns conforming with the NGS tests.